Trial intelligence / Profile preview

Triamcinolone Acetonide for pain reduction with orthodontic elastomeric separators

IRCT20240915063040N1Phase 3Completed

Sponsor
Islamic Azad University
Start
Nov 2024
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of triamcinolone acetonide in orthodontic pain, sponsored by Islamic Azad University. Started Nov 2024; status: completed.

02

Drugs

triamcinolone acetonide
03

Conditions

orthodontic pain

Beyond the preview

Go deeper on IRCT20240915063040N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20240915063040N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call